tacrolimus 0.1%

DRUG4 trials

Sponsors

Astellas Pharma Inc, University of Peradeniya, Shalamar Institute of Health Sciences, Hayat Abad Medical Complex, Peshawar

Conditions

Atopic DermatitisAtopic Dermatitis (AD)Dermatitis, AtopicOral Lichen Planus

Phase 2

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

CompletedNCT02744378

University of PeradeniyaOral Lichen Planus

Start: 2014-06-30End: 2015-12-31Updated: 2016-04-20

Phase 3

Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

Not yet recruitingNCT07162896

Shalamar Institute of Health SciencesAtopic Dermatitis, Atopic Dermatitis (AD)

Start: 2026-06-30End: 2027-06-30Target: 66Updated: 2025-09-09

Phase 4

Protopic Ointment in Adult Atopic Eczema of the Face

CompletedNCT00690105

Astellas Pharma IncDermatitis, Atopic

Start: 2004-02-29End: 2005-07-31Updated: 2014-09-01

Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis

Not yet recruitingNCT07437534

Hayat Abad Medical Complex, PeshawarAtopic Dermatitis

Start: 2026-03-01End: 2026-08-30Target: 148Updated: 2026-03-02